posted on Tuesday, 21st October 2014
The CaPP3 Study is funded by Cancer Research UK through the
Stand up to Cancer Campaign. The recent TV fund-raising event has
raised so far £14,520,756. The week before, the UK took part in the
"March on Cancer" events held in 15 cities across the UK. Gill
Borthwick (pictured right), the Cancer Prevention Programme
Manager, represented the CaPP3 Study in Newcastle.
The CaPP3 study opened to recruitment at the Institute of
Genetic Medicine, Newcastle on Wednesday 1st October 2014.
Professor Sir John Burn consented the first recruit.
The first batch of packed aspirin has been delivered to the
pharmacy in Newcastle ready for dispensing.
The study will be recruiting through all the UK Regional
Genetics Centres. Over the next few months these centres too will
be opening to recruitment, once they have completed their local
So after several long years of working our way through UK
regulatory processes the CaPP3 study is finally open to